Gene Synthesis Market Research Report Information by Method (Solid-phase Synthesis, Chip-based DNA Synthesis, PCR Based Enzyme Synthesis), by Services (Antibody DNA Synthesis, Viral DNA Synthesis, Others), by Application (Protein Engineering, Vaccine Design & Development, Disease Diagnosis, Therapeutic Antibodies, Others), by End User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations), and by Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast till 2032
ID: MRFR/HC/10104-HCR | 128 Pages | Author: Rahul Gotadki | November 2023
Gene Synthesis Market Segmentation
Gene Synthesis Market Method Outlook (USD Billion, 2019-2032)
- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
Gene Synthesis Market Services Outlook (USD Billion, 2019-2032)
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
Gene Synthesis Market Application Outlook (USD Billion, 2019-2032)
- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
Gene Synthesis Market End User Outlook (USD Billion, 2019-2032)
- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
Gene Synthesis Regional Outlook (USD Billion, 2019-2032)
-
North America Outlook (USD Billion, 2019-2032)-
North America Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
North America Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
North America Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
North America Gene Synthesis by End UserÂ- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- US Outlook (USD Billion, 2019-2032)
-
US Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
US Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
US Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
US Gene Synthesis by End UserÂ- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- Canada Outlook (USD Billion, 2019-2032)
-
Canada Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Canada Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Canada Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Canada Gene Synthesis by End UserÂ- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Europe Outlook (USD Billion, 2019-2032)-
Europe Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Europe Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Europe Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Europe Gene Synthesis by End UserÂ- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Germany Outlook (USD Billion, 2019-2032) -
Germany Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Germany Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Germany Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Germany Gene Synthesis by End UserÂ- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- France Outlook (USD Billion, 2019-2032)
-
France Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
France Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
France Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
France Gene Synthesis by End UserÂ- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- UK Outlook (USD Billion, 2019-2032)
-
UK Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
UK Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
UK Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
UK Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- Italy Outlook (USD Billion, 2019-2032)
-
Italy Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Italy Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Italy Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Italy Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- Spain Outlook (USD Billion, 2019-2032)
-
Spain Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Spain Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Spain Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Spain Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
- Rest Of Europe Outlook (USD Billion, 2019-2032)
-
Rest Of Europe Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Rest of Europe Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Rest of Europe Gene Synthesis by ApplicationÂ- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Rest of Europe Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Asia-Pacific Outlook (USD Billion, 2019-2032)-
Asia-Pacific Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Asia-Pacific Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Asia-Pacific Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Asia-Pacific Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Japan Outlook (USD Billion, 2019-2032) -
Japan Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Japan Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Japan Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Japan Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
China Outlook (USD Billion, 2019-2032) -
China Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
China Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
China Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
China Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
India Outlook (USD Billion, 2019-2032) -
India Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
India Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
India Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
India Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Australia Outlook (USD Billion, 2019-2032) -
Australia Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Australia Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Australia Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Australia Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
South Korea Outlook (USD Billion, 2019-2032) -
South Korea Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
South Korea Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
South Korea Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
South Korea Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Rest of Asia-Pacific Outlook (USD Billion, 2019-2032) -
Rest of Asia-Pacific Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Rest of Asia-Pacific Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Rest of Asia-Pacific Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Rest of Asia-Pacific Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Rest of the World Outlook (USD Billion, 2019-2032)-
Rest of the World Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Rest of the World Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Rest of the World Gene Synthesis by ApplicationÂ- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Rest of the World Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Middle East Outlook (USD Billion, 2019-2032) -
Middle East Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Middle East Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Middle East Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Middle East Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Africa Outlook (USD Billion, 2019-2032) -
Africa Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Africa Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Africa Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Africa Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
Latin America Outlook (USD Billion, 2019-2032) -
Latin America Gene Synthesis by Method- Solid-phase Synthesis
- Chip-based DNA Synthesis
- PCR Based Enzyme Synthesis
-
Latin America Gene Synthesis by ServicesÂ- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
-
Latin America Gene Synthesis by Application- Protein Engineering
- Vaccine Design & Development
- Disease Diagnosis
- Therapeutic Antibodies
- Others
-
Latin America Gene Synthesis by End User- Biotechnology & Pharmaceutical Companies
- Academic & Government Contract Research Organizations
- Contract Research Organizations
-
-
-
-
Leading companies partner with us for data-driven Insights.
